Frankfurt
06.02.26 | 16:05
0,151 Euro
-9,04 % -0,015
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.01. | Vext Science Inc: Vext Science investor Nguyen sells 20,340 shares | 7 | Stockwatch | ||
| 11.12.25 | VEXT Science, Inc.: Vext Announces Voting Results of Annual General Meeting | 363 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 20.11.25 | VEXT Science, Inc.: Vext Reports Q3 2025 Financial Results | 984 | Newsfile | Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations... ► Artikel lesen | |
| 20.11.25 | Vext Science Inc: Vext Science has EBITDA of $2.31M (U.S.) in Q3 2025 | 4 | Stockwatch | ||
| 20.11.25 | Vext Science reports Q3 results | 4 | Seeking Alpha | ||
| 11.11.25 | Vext Science Inc: Vext Science to release Q3 2025 results Nov. 20 | 1 | Stockwatch | ||
| 11.11.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q3 2025 on November 20, 2025 | 351 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 17.09.25 | Vext Science Inc: Vext receives OK for Ohio dispensary ownership transfer | 1 | Stockwatch | ||
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| 17.09.25 | VEXT Science, Inc.: Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer | 353 | Newsfile | Upon closing, expected by October 1, 2025, Portsmouth will become Vext's fifth fully consolidated dispensary in Ohio. The Company expects to bring additional locations online through late 2025 and... ► Artikel lesen | |
| 20.08.25 | Vext Science reports Q2 results | 6 | Seeking Alpha | ||
| 20.08.25 | VEXT Science, Inc.: Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin | 523 | Newsfile | Record financial performance, with growth in revenue, adjusted EBITDA, and operating cash flow driven by strong Ohio momentum and disciplined operations in Arizona.Revenue of $13.4 million, up 59%... ► Artikel lesen | |
| 11.08.25 | Vext Science Inc: Vext Science to issue, host call for Q2 results Aug. 20 | 1 | Stockwatch | ||
| 11.08.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q2 2025 on August 20, 2025 | 332 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
| 24.06.25 | VEXT Science, Inc.: Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield | 362 | Newsfile | Secures a provisional license for sixth Ohio dispensary in Fairfield, with operations expected to begin in Q4 2025, subject to regulatory approvals.Demonstrates Vext's strategic approach to retail... ► Artikel lesen | |
| 16.06.25 | VEXT Science, Inc.: Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market | 360 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 16, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 05.06.25 | VEXT Science, Inc.: Vext Announces Change of Auditor | 602 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 21.05.25 | VEXT Science, Inc.: Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue | 470 | Newsfile | Revenue grew 38% to $11.6 million compared to $8.4 million in Q1 2024, and up 13% sequentially from $10.2 million in Q4 2024, driven by growth in Ohio.Q1 2025 operating cash flow reached $3.1 million... ► Artikel lesen | |
| 13.05.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q1 2025 on May 21, 2025 | 417 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 13, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 04.04.25 | VEXT Science, Inc.: Vext Strengthens Balance Sheet and Sharpens Focus on Core Markets with Strategic Sale of Kentucky Medical Processing License | 524 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertically integrated operations... ► Artikel lesen | |
| 03.04.25 | VEXT Science, Inc.: Vext Completes Ohio Expansion Transaction, Expanding Ohio Retail Presence to Four Dispensaries | 503 | Newsfile | Vext now operates four retail dispensaries in Ohio's limited license market and remains on track to reach the state license cap of eight (8) total dispensaries, with new locations expected to open... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,925 | -0,85 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2026 Third Quarter Results | NASDAQ | TSX: ACB
Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 million
... ► Artikel lesen | |
| CANOPY GROWTH | 0,935 | -0,95 % | Canopy Growth: Treffer ohne Gewinn - Trading-Tipp wird zurückgezogen | ||
| TILRAY BRANDS | 6,450 | +0,62 % | Tilray Brands, Inc.: CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet | Die Auszeichnung würdigt CC Pharma als innovativen Marktführer und vertrauenswürdigen Partner auf dem europäischen PharmamarktDENSBORN, Deutschland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma,... ► Artikel lesen | |
| INNOCAN PHARMA | 4,020 | -3,37 % | INNOCAN PHARMA im Fokus ruhiger Neubewertung | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,252 | +0,63 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
| SYNBIOTIC | 2,040 | -0,49 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| DIGICANN VENTURES | 0,001 | -75,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,250 | -4,58 % | Organigram Global Inc: Organigram to release fiscal Q1 results Feb. 10 | ||
| GREEN THUMB INDUSTRIES | 5,975 | -1,89 % | Green Thumb Industries Inc: Green Thumb to release 2025 results Feb. 25 | ||
| SNDL | 1,254 | -2,18 % | 1CM Inc.: SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased... ► Artikel lesen | |
| CRESCO LABS | 0,896 | +0,73 % | Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry | Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump's action to... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,155 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 03.02.2026 | Das Instrument 0NF CA62849F4087 MYDECINE INNOVAT.GRP NEW EQUITY wird cum Kapitalmassnahme gehandelt am 03.02.2026 und ex Kapitalmassnahme am 04.02.2026 The instrument 0NF CA62849F4087 MYDECINE INNOVAT.GRP... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 3,480 | -1,69 % | Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS) | TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 1,070 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly's Yolks Breakfast Signs Franchise Agreement and Real-Estate Location in the City of Langley, British Columbia | Toronto, Ontario--(Newsfile Corp. - January 26, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFG) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen |
VEXT SCIENCE INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -9,04 % bei einem Aktienkurs von 0,151 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.